Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 22.4B | 29.4B | 24.4B | 22.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 288.3M | 414.7M | 1.0B | 812.7M |
Other operating expenses | 167.3M | 3.5B | 89.7M | 88.3M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 0 | 3.2B | 0 | 0 |
Pretax income | 1.6B | 1.2B | 1.2B | 894.7M |
Tax provision | 223.3M | 0 | 0 | 0 |
Net income | 1.4B | 1.2B | 1.2B | 894.7M |
Basic EPS | 1.5 | — | 1.3 | 1.0 |
Diluted EPS | 1.5 | — | 1.3 | 1.0 |
Basic average shares | 922.2M | — | 918.8M | 922.4M |
Diluted average shares | 928.4M | — | 925.9M | 932.0M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |